Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyskeratosis congenita.

T P B Handley1, J A McCaul, G R Ogden

  • 1Unit of Oral Surgery and Medicine, University of Dundee, Park Place, Dundee DD1 4HR, and Department of Oral and Maxillofacial Surgery, Monklands Hospital, Airdre, UK.

Oral Oncology
|September 6, 2005
PubMed
Summary

Dyskeratosis congenita is a rare inherited disorder characterized by oral leukoplakia, nail dystrophy, and skin pigmentation, often leading to premature death from bone marrow failure or cancer. Understanding its genetic basis, including DKC1 and TERC gene mutations, is key to improving diagnosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial-myoepithelial carcinoma of the maxillofacial and sinonasal region: a systematic review of presenting characteristics, treatment modalities, and associated outcomes.

International journal of oral and maxillofacial surgery·2022
Same author

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).

European journal of cancer (Oxford, England : 1990)·2020
Same author

Immunotherapy in the management of squamous cell carcinoma of the head and neck.

The British journal of oral & maxillofacial surgery·2019
Same author

Alcohol and mouth cancer.

British dental journal·2018
Same author

Recruitment of patients into head and neck clinical trials: acceptability of studies to patients from perspective of the research team.

The British journal of oral & maxillofacial surgery·2018
Same author

Management of cervicofacial infections: a survey of current practice in maxillofacial units in the UK.

The British journal of oral & maxillofacial surgery·2017

Area of Science:

  • Genetics
  • Dermatology
  • Hematology

Background:

  • Dyskeratosis congenita (DC) is a rare inherited disorder.
  • It typically presents with a triad of oral leukoplakia, nail dystrophy, and skin pigmentation.
  • While often X-linked, autosomal dominant and recessive forms exist.

Purpose of the Study:

  • To summarize the key features and genetic underpinnings of Dyskeratosis congenita.
  • To highlight the clinical significance and diagnostic challenges of this rare syndrome.
  • To emphasize the need for increased understanding of its molecular biology for improved patient outcomes.

Main Methods:

  • Review of existing literature on Dyskeratosis congenita.
  • Analysis of genetic mutations associated with different inheritance patterns (DKC1, TERC).

Related Experiment Videos

  • Compilation of clinical manifestations and associated mortality risks.

    • Main Results:

    • Dyskeratosis congenita presents with characteristic mucocutaneous findings and significant risks of bone marrow failure and malignancy.
    • Genetic defects in DKC1 (X-linked) and TERC (autosomal dominant) are identified causes.
    • Early identification of oral leukoplakia in children can be a crucial diagnostic clue.

    Conclusions:

    • Dyskeratosis congenita is a serious genetic disorder with significant morbidity and mortality.
    • Understanding the molecular basis of DC is crucial for advancing diagnostic accuracy, disease monitoring, and therapeutic strategies.
    • Increased clinical suspicion and genetic testing are vital for timely diagnosis and management.